Oculocutaneous albinism
| Oculocutaneous albinism | |
|---|---|
| Term | Oculocutaneous albinism |
| Short definition | octreotide - (pronounced) (ok-TREE-oh-tide) drug similar to the naturally occurring growth hormone inhibitor somatostatin. Octreotide is used to treat diarrhea and flushing associated with certain types of tumours |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
oculocutaneous albinism - (pronounced) (AH-kyoo-loh-kyoo-TAY-nee-us AL-bih-NIH-zum) group of rare inherited disorders in which there is little or no melanin (pigment) in the skin, hair, and eyes. Most people with these disorders have very pale skin, white or light-colored hair, and light-colored eyes. People with oculocutaneous albinism can also have vision problems, including blurred vision, rapid eye movement, squinting, and increased sensitivity to light. People with these disorders are at high risk of developing squamous cell carcinoma of the skin at a very young age. The seven types of oculocutaneous albinism are caused by mutations (changes) in the TYR, OCA2, TYRP1, SLC45A2, OCA5, SLC24A5, or C10orf11 gene. These genes are involved in the production of melanin. The amount of skin, hair, and eye pigment seen in each type of oculocutaneous albinism depends on the gene and mutation involved. Also called OCA
External links
- Medical encyclopedia article on Oculocutaneous albinism
- Wikipedia's article - Oculocutaneous albinism
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski